• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACETABULAR HIP; EMPOWR ACETABULAR SYSTEM, LINER, NEUTRAL, HXE+, 36H

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACETABULAR HIP; EMPOWR ACETABULAR SYSTEM, LINER, NEUTRAL, HXE+, 36H Back to Search Results
Model Number 941-01-36H
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 09/02/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional reporting on this event will be provided as a supplemental report to this document if it becomes available.
 
Event or Problem Description
Revision surgery - the patient was infected.
 
Additional Manufacturer Narrative
The reason for this revision surgery was reported as infection.The previous surgery and the surgery detailed in this event occurred 14 days apart.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The devices were disposed of at the hospital and not made available to djo surgical for examination.A review of the device history records (dhr) show that the reported components used in the previous surgery, when released for use, met design and manufacturing requirements.There were no non-conforming material reports (ncmr) associated with the products that may have contributed to the reported event.The devices were verified to have gone through an acceptable sterilization process and were within its expiration date at the time of the previous surgery.Customer complaint history of the reported devices showed no present trends or on-going issues that are needing a review.The root cause of this complaint was a revision surgery due to an infection.There were no findings during this evaluation that indicate the reported devices were the source or had a direct connection with the patient's infection.No information was submitted with the complaint regarding pre-existing conditions of the patient or any activities the patient was involved in that may have contributed to the infection or inhibited the patient's immune system.Due to short time between the original surgery and the revision, it is possible that the infection was acquired in the hospital (nosocomial).It is also possible that the patient was not compliant with post-surgical instructons.There are multiple factors that may contribute to an infection that are outside the control of djo surgical.There are no indications of a product or process issue affecting implant safety or effectiveness.Additional reporting on this event will be provided as a supplemental report to this document if it becomes available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACETABULAR HIP
Common Device Name
EMPOWR ACETABULAR SYSTEM, LINER, NEUTRAL, HXE+, 36H
MDR Report Key10613648
Report Number1644408-2020-00858
Device Sequence Number3818942
Product Code LPH
UDI-Device Identifier00190446309543
UDI-Public(01)00190446309543
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K190057
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 11/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/14/2025
Device Model Number941-01-36H
Device Catalogue Number941-01-36H
Device Lot Number600Z1030
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 09/02/2020
Supplement Date Received by Manufacturer10/14/2020
Initial Report FDA Received Date10/01/2020
Supplement Report FDA Received Date11/13/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
400-03-362 LOT 866B1682; 400-03-362 LOT 866B1682
Outcome Attributed to Adverse Event Required Intervention;
Patient Age71 YR
-
-